San Francisco reaches $58 mln opioid settlement with Teva, Allergan | Reuters
Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
Teva buys Allergan's generic drug unit for $40.5B
Teva wants Allergan's distribution biz now that $40B drug deal has closed | Fierce Pharma
Allergan: Restasis Is Under Siege By Mylan And Teva (NYSE:AGN) | Seeking Alpha
Allergan to Sell Teva Shares to J.P. Morgan | Ctech
Teva deal lets us double down on brands: Allergan CEO
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
AG Reaches $33.3M Agreement with Teva, Allergan; Opioid Makers Agree to Restrictions on Sales, Marketing - InDepthNH.orgInDepthNH.org
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Allergan steps away from generics with sale to Teva | Business | Chemistry World
Allergan announces sale of Anda distribution business to Teva Pharmaceuticals
Teva agrees to buy Allergan's generics distribution unit
Allergan: Restasis Is Under Siege By Mylan And Teva (NYSE:AGN) | Seeking Alpha
Teva to Divest 79 Generic Drugs to Settle FTC Concerns With Allergan Generics Acquisition | RAPS
Purchase of Allergan and Sale of Teva - Vitaliy Katsenelson Contrarian Edge
Allergan to Sell Teva Shares to J.P. Morgan | Ctech
Teva Can Reach $100 on Allergan Unit Acquisition | Barron's
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters
Teva deal lets us double down on brands: Allergan CEO
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Allergan to sell a quarter of its Teva stake in first quarter of 2018 | Reuters
New York Opioid Trial: Allergan Settlement Leaves Teva as Last Target - Bloomberg
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
